CYTOKINETICS INC (CYTK) Form 10-K Annual Reports
CYTOKINETICS INC (CYTK) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CYTK
CIK: 1061983
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerDaniel Coleman
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-12 | PRIMARY DOCUMENT | 0001061983-26-000099 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001950047-26-010157 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-06 | PRIMARY DOCUMENT | 0001061983-26-000098 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-28 | PRIMARY DOCUMENT | 0001061983-26-000097 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-22 | PRIMARY DOCUMENT | 0001061983-26-000096 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001968582-26-000978 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | PRIMARY DOCUMENT | 0001061983-26-000095 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | PRIMARY DOCUMENT | 0001061983-26-000094 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-11 | PRIMARY DOCUMENT | 0001061983-26-000093 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009347 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | PRIMARY DOCUMENT | 0001061983-26-000092 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | PRIMARY DOCUMENT | 0001061983-26-000091 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008948 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | PRIMARY DOCUMENT | 0001061983-26-000090 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | PRIMARY DOCUMENT | 0001061983-26-000089 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-28 | 8-K | 0001193125-26-372456 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-18 | PRIMARY DOCUMENT | 0001061983-26-000088 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000902219-26-000255 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-348060 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-10 | PRIMARY DOCUMENT | 0001061983-26-000087 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338217 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338021 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-30 | PRIMARY DOCUMENT | 0001061983-26-000086 | View SEC Doc Filr Page |
| 144 | 2026-07-30 | — | 144 Filing | 0001950047-26-007436 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-27 | PRIMARY DOCUMENT | 0001061983-26-000085 | View SEC Doc Filr Page |